Dr Joseph D Eddings, MD | |
8140 N Mopac Expy Bldg Iii, Suite 210, Austin, TX 78759-8837 | |
(512) 343-2292 | |
(512) 343-2745 |
Full Name | Dr Joseph D Eddings |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 27 Years |
Location | 8140 N Mopac Expy Bldg Iii, Austin, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407894918 | NPI | - | NPPES |
1440117-03 | Medicaid | TX | |
8AG655 | Other | TX | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | K7725 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Round Rock Medical Center | Round rock, TX | Hospital |
St David's Medical Center | Austin, TX | Hospital |
North Austin Medical Center | Austin, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Austin Anesthesiology Group Pllc | 0547256497 | 374 |
News Archive
The Philadelphia Inquirer on Sunday examined the efficacy of Genomic Health's Oncotype DX test and Amsterdam, Netherlands-based Agendia's MammaPrint, both of which measure a woman's odds of breast cancer relapse by testing her removed tumor for genes that can predict the likelihood of her cancer returning.
The Associated Press: A quarter of heart doctors order more tests than were necessary, driving up costs, according to a new study. "Most said they weren't swayed by such things as financial gain or a patient's expectations.
Chugai Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by Chugai, for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors, administered once weekly, every two weeks, or every four weeks.
New research shows it could be possible to follow the spread of bacterial sexually transmitted diseases (STDs) through the population by tracking the individuals in a city infected with the same strain of the bacterium.
Researchers at the University of Colorado School of Medicine have created a new and exciting mouse model to study how lipid sensing and metabolism in the brain relate to the regulation of energy balance and body weight. The research team, led by Hong Wang, PhD, created mice with a deficiency of lipoprotein lipase (LPL) in neurons, and observed two important reactions.
› Verified 5 days ago
Entity Name | Austin Anesthesiology Group Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598724304 PECOS PAC ID: 0547256497 Enrollment ID: O20040424000086 |
News Archive
The Philadelphia Inquirer on Sunday examined the efficacy of Genomic Health's Oncotype DX test and Amsterdam, Netherlands-based Agendia's MammaPrint, both of which measure a woman's odds of breast cancer relapse by testing her removed tumor for genes that can predict the likelihood of her cancer returning.
The Associated Press: A quarter of heart doctors order more tests than were necessary, driving up costs, according to a new study. "Most said they weren't swayed by such things as financial gain or a patient's expectations.
Chugai Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by Chugai, for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors, administered once weekly, every two weeks, or every four weeks.
New research shows it could be possible to follow the spread of bacterial sexually transmitted diseases (STDs) through the population by tracking the individuals in a city infected with the same strain of the bacterium.
Researchers at the University of Colorado School of Medicine have created a new and exciting mouse model to study how lipid sensing and metabolism in the brain relate to the regulation of energy balance and body weight. The research team, led by Hong Wang, PhD, created mice with a deficiency of lipoprotein lipase (LPL) in neurons, and observed two important reactions.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Joseph D Eddings, MD 8140 N Mopac Expy Bldg Iii, Suite 210, Austin, TX 78759-8837 Ph: (512) 343-2292 | Dr Joseph D Eddings, MD 8140 N Mopac Expy Bldg Iii, Suite 210, Austin, TX 78759-8837 Ph: (512) 343-2292 |
News Archive
The Philadelphia Inquirer on Sunday examined the efficacy of Genomic Health's Oncotype DX test and Amsterdam, Netherlands-based Agendia's MammaPrint, both of which measure a woman's odds of breast cancer relapse by testing her removed tumor for genes that can predict the likelihood of her cancer returning.
The Associated Press: A quarter of heart doctors order more tests than were necessary, driving up costs, according to a new study. "Most said they weren't swayed by such things as financial gain or a patient's expectations.
Chugai Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by Chugai, for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors, administered once weekly, every two weeks, or every four weeks.
New research shows it could be possible to follow the spread of bacterial sexually transmitted diseases (STDs) through the population by tracking the individuals in a city infected with the same strain of the bacterium.
Researchers at the University of Colorado School of Medicine have created a new and exciting mouse model to study how lipid sensing and metabolism in the brain relate to the regulation of energy balance and body weight. The research team, led by Hong Wang, PhD, created mice with a deficiency of lipoprotein lipase (LPL) in neurons, and observed two important reactions.
› Verified 5 days ago
Dr. John W Wages, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4100 Duval Rd, Bldg Iii Suite 200, Austin, TX 78759 Phone: 512-485-7200 Fax: 512-485-7224 | |
Allison Rae Losey, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy, Suite 570, Austin, TX 78705 Phone: 512-454-2554 | |
Dr. James Patrick Fogarty Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8140 N Mopac Expy Ste 3-210, Austin, TX 78759 Phone: 512-343-2292 | |
Vijay K. Ravula, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-476-7111 | |
Gary L. Mihm, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-476-7111 | |
Todd Paricio, M.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3801 N Lamar Blvd, Austin, TX 78756 Phone: 512-407-8444 Fax: 512-407-8097 | |
Dr. Rebecca R Porras, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3705 Medical Pkwy, Suite 570, Austin, TX 78705 Phone: 512-454-2454 Fax: 512-454-1532 |